For example, typical signs of pyroptosis such as upregulation of caspase-1 and interleukin 1β (IL-1β) in myocardial infarction (MI) have been reported [6], suggesting that modulation of pyroptosis may be a viable therapeutic target for alleviating selective cardiovascular diseases such as MI. The gene discussed is CASP1; the disease is myocardial infarction.